Clinical trials for Myelodysplasia

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Myelodysplasia. For all clinical trials, go to clinical trials search

This list shows clinical trials for Myelodysplasia

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Myelodysplasia
Title Recruitment status Location
Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome. Recruiting United Kingdom
Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure Recruiting United Kingdom
A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients Recruiting United Kingdom
Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) Recruiting United Kingdom
The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS) Recruiting United Kingdom
A Phase I/II study of Azacitidine (Vidaza®) in pediatric patients with newly diagnosed or relapsed high-grade pediatric MDS or JMML Recruiting United Kingdom
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA Recruiting United Kingdom
Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q) Recruiting United Kingdom
Safety and Efficacy Study of CC-486 and Durvalumab in Subjects With Myelodysplastic Syndromes Recruiting United Kingdom
Assessing the safety and tolerability of oral Ruxolitinib in combination with 5-azacitidine in patients with advanced phase myeloproliferative neoplasms (MPN), including myelodysplastic syndromes (MDS) or acute myeloid leukaemia (AML) arising from MPN. Recruiting United Kingdom

Page last reviewed: 05/11/2014

Next review due: 05/11/2017